Filing Details

Accession Number:
0001179110-16-020668
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-02 17:14:19
Reporting Period:
2016-02-29
Filing Date:
2016-03-02
Accepted Time:
2016-03-02 17:14:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1452290 J Michael Warmuth 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2016-02-29 24,033 $0.00 69,217 No 4 A Direct
Common Shares Without Par Value Disposition 2016-02-29 4,807 $39.52 64,410 No 4 F Direct
Common Shares Without Par Value Disposition 2016-02-29 2,799 $38.84 61,611 No 4 S Direct
Common Shares Without Par Value Disposition 2016-02-29 6,600 $38.85 55,011 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 29,586 Indirect By trust
Footnotes
  1. Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
  2. Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.